Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer’s-like pathology

Microglial proliferation and activation is a hallmark of Alzheimer’s disease. Olmos-Alonso et al. show that microglial proliferation in Alzheimer’s disease tissue correlates with overactivation of the colony-stimulating factor 1 receptor (CSF1R) pathway. CSF1R blockade arrests microglial proliferation and activation in a mouse model of Alzheimer-like pathology and slows disease progression.

[1]  O. Garaschuk,et al.  Impairment of in vivo calcium signaling in amyloid plaque-associated microglia , 2014, Acta Neuropathologica.

[2]  D. Hume,et al.  Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. , 2012, Blood.

[3]  Manolis Kellis,et al.  Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer’s disease , 2015, Nature.

[4]  Christina S. Leslie,et al.  CSF-1R inhibition alters macrophage polarization and blocks glioma progression , 2013, Nature Medicine.

[5]  V. Perry,et al.  Microglia in neurodegenerative disease , 2010, Nature Reviews Neurology.

[6]  A. Singleton,et al.  TREM2 variants in Alzheimer's disease. , 2013, The New England journal of medicine.

[7]  G. Schwartz,et al.  Sustained Inhibition of Receptor Tyrosine Kinases and Macrophage Depletion by PLX3397 and Rapamycin as a Potential New Approach for the Treatment of MPNSTs , 2014, Clinical Cancer Research.

[8]  Shengxiang Zhang,et al.  Proliferation of parenchymal microglia is the main source of microgliosis after ischaemic stroke. , 2013, Brain : a journal of neurology.

[9]  P. Mcgeer,et al.  Expression of the receptor for macrophage colony stimulating factor by brain microglia and its upregulation in brains of patients with Alzheimer's disease and amyotrophic lateral sclerosis , 1994, Brain Research.

[10]  J. Grutzendler,et al.  Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques , 2014, Nature Communications.

[11]  F. Pixley,et al.  CSF-1 regulation of the wandering macrophage: complexity in action. , 2004, Trends in cell biology.

[12]  W. Markesbery,et al.  Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Brian L. West,et al.  Colony-Stimulating Factor 1 Receptor Signaling Is Necessary for Microglia Viability, Unmasking a Microglia Progenitor Cell in the Adult Brain , 2014, Neuron.

[14]  F. LaFerla,et al.  Alzheimer's disease: Aβ, tau and synaptic dysfunction , 2005 .

[15]  F. Heppner,et al.  Formation and maintenance of Alzheimer's disease β-amyloid plaques in the absence of microglia , 2009, Nature Neuroscience.

[16]  B. Hyman,et al.  Microglial response to amyloid plaques in APPsw transgenic mice. , 1998, The American journal of pathology.

[17]  Frank M LaFerla,et al.  Alzheimer's disease: Abeta, tau and synaptic dysfunction. , 2005, Trends in molecular medicine.

[18]  V. Perry,et al.  Systemic inflammation and disease progression in Alzheimer disease , 2009, Neurology.

[19]  Miranka Wirth,et al.  Alzheimer's Disease Neurodegenerative Biomarkers Are Associated with Decreased Cognitive Function but Not β-Amyloid in Cognitively Normal Older Individuals , 2013, The Journal of Neuroscience.

[20]  A. Hofman,et al.  Variant of TREM2 associated with the risk of Alzheimer's disease. , 2013, The New England journal of medicine.

[21]  M. Staufenbiel,et al.  Amyloid-Associated Neuron Loss and Gliogenesis in the Neocortex of Amyloid Precursor Protein Transgenic Mice , 2002, The Journal of Neuroscience.

[22]  J. Pollard,et al.  Absence of Colony Stimulation Factor-1 Receptor Results in Loss of Microglia, Disrupted Brain Development and Olfactory Deficits , 2011, PloS one.

[23]  D. Dickson,et al.  Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease , 1993, Glia.

[24]  F. Ginhoux,et al.  Stroma-derived interleukin-34 controls the development and maintenance of langerhans cells and the maintenance of microglia. , 2012, Immunity.

[25]  Nick C Fox,et al.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.

[26]  Elisa Cerutti,et al.  Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and β-catenin , 2009, Nature Immunology.

[27]  A. Mildner,et al.  Distinct and Non-Redundant Roles of Microglia and Myeloid Subsets in Mouse Models of Alzheimer's Disease , 2011, The Journal of Neuroscience.

[28]  B. Tomczuk,et al.  JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia , 2009, Molecular Cancer Therapeutics.

[29]  R. Veerhuis,et al.  Soothing the inflamed brain: effect of non-steroidal anti-inflammatory drugs on Alzheimer's disease pathology. , 2011, CNS & neurological disorders drug targets.

[30]  K. Lunetta,et al.  Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. , 2010, Archives of neurology.

[31]  M. Ziebell,et al.  Multidimensional Profiling of CSF1R Screening Hits and Inhibitors , 2011, Journal of biomolecular screening.

[32]  Lee B. Smith,et al.  Pleiotropic effects of extended blockade of CSF1R signaling in adult mice , 2014, Journal of leukocyte biology.

[33]  V. Perry,et al.  Analysis of Microglial Proliferation in Alzheimer's Disease. , 2016, Methods in molecular biology.

[34]  M. Mattson,et al.  3xTgAD mice exhibit altered behavior and elevated Aβ after chronic mild social stress , 2012, Neurobiology of Aging.

[35]  V. Perry,et al.  Regulation of Microglial Proliferation during Chronic Neurodegeneration , 2013, The Journal of Neuroscience.

[36]  M. Diamond,et al.  IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia , 2012, Nature Immunology.

[37]  D. Gomez-Nicola,et al.  Differential role of CCR2 in the dynamics of microglia and perivascular macrophages during prion disease , 2014, Glia.

[38]  R O Weller,et al.  Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain. , 2008, Brain : a journal of neurology.

[39]  K. Jellinger,et al.  Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature , 2012, Journal of neuropathology and experimental neurology.

[40]  L. Williams,et al.  Functional overlap but differential expression of CSF‐1 and IL‐34 in their CSF‐1 receptor‐mediated regulation of myeloid cells , 2010, Journal of leukocyte biology.

[41]  F. Ginhoux,et al.  Origin and differentiation of microglia , 2013, Front. Cell. Neurosci..

[42]  D. Gomez-Nicola,et al.  Interleukin 15 expression in the CNS: Blockade of its activity prevents glial activation after an inflammatory injury , 2008, Glia.

[43]  A. Wilks,et al.  c-FMS inhibitors: a patent review , 2011, Expert opinion on therapeutic patents.

[44]  V. Perry,et al.  Microglial Dynamics and Role in the Healthy and Diseased Brain , 2015, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[45]  G. Murphy,et al.  Expression of macrophage colony-stimulating factor receptor is increased in the AbetaPP(V717F) transgenic mouse model of Alzheimer's disease. , 2000, The American journal of pathology.

[46]  Marina A. Lynch,et al.  How dependent is synaptic plasticity on microglial phenotype? , 2015, Neuropharmacology.

[47]  V. Perry,et al.  Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease , 2003, The European journal of neuroscience.

[48]  Michael C. Ostrowski,et al.  A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse. , 2003, Blood.

[49]  F. Heppner,et al.  Formation and maintenance of Alzheimer’s disease beta-amyloid plaques in the absence of microglia , 2010 .

[50]  Berislav V. Zlokovic,et al.  Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging , 2010, Neuron.

[51]  J..  Neurodegenerative Diseases , 1996, GWUMC Department of Biochemistry and Molecular Biology Annual Spring Symposia.

[52]  Martin Rossor,et al.  Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study , 2008, Neurobiology of Disease.

[53]  Mathias Jucker,et al.  The benefits and limitations of animal models for translational research in neurodegenerative diseases , 2010, Nature Medicine.

[54]  E. Hol,et al.  Differential cell proliferation in the cortex of the appsweps1de9 alzheimer's disease mouse model , 2012, Glia.

[55]  Christian Hölscher,et al.  The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease , 2011, The Journal of Neuroscience.

[56]  D. Gomez-Nicola,et al.  Interleukin-15 regulates proliferation and self-renewal of adult neural stem cells , 2011, Molecular biology of the cell.

[57]  D. Gomez-Nicola,et al.  Post-mortem analysis of neuroinflammatory changes in human Alzheimer’s disease , 2015, Alzheimer's Research & Therapy.

[58]  L. Tran,et al.  Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease , 2013, Cell.

[59]  C. Plata-salamán,et al.  Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.

[60]  S. Gambhir,et al.  Antiviral drug ganciclovir is a potent inhibitor of microglial proliferation and neuroinflammation , 2014, The Journal of experimental medicine.

[61]  Ian G. McKeith,et al.  Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales , 2001, The Lancet.

[62]  F. Ginhoux,et al.  Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells , 2008, Nature Reviews Immunology.

[63]  D. Holtzman,et al.  Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2 , 2014, Molecular Neurodegeneration.

[64]  V. Perry,et al.  Temporal dynamics of hippocampal neurogenesis in chronic neurodegeneration , 2014, Brain : a journal of neurology.

[65]  Chandler D. Gatenbee,et al.  Cytokine expression and microglial activation in progressive supranuclear palsy. , 2011, Parkinsonism & related disorders.

[66]  V. Perry,et al.  Proinflammatory cytokines, sickness behavior, and Alzheimer disease , 2011, Neurology.